Diabetes mellitus type 2 secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Diabetes mellitus type 2}} | {{Diabetes mellitus type 2}} | ||
{{CMG}}; {{AE}} {{MehdiP}} | |||
{{CMG}}; {{AE}} | |||
==Overview== | ==Overview== | ||
== Secondary Prevention == | == Secondary Prevention == | ||
=== | Secondary prevention is focused to decrease the macrovascular complications. Application of effective strategies can result in up to 50% risk reduction in macrovascular complications.<ref name="pmid12556541">{{cite journal |vauthors=Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O |title=Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes |journal=N. Engl. J. Med. |volume=348 |issue=5 |pages=383–93 |year=2003 |pmid=12556541 |doi=10.1056/NEJMoa021778 |url=}}</ref> Effective measures in this case include:<ref name="pmid14734596">{{cite journal |vauthors=Saydah SH, Fradkin J, Cowie CC |title=Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes |journal=JAMA |volume=291 |issue=3 |pages=335–42 |year=2004 |pmid=14734596 |doi=10.1001/jama.291.3.335 |url=}}</ref> | ||
==== | *Glycemic control | ||
*Treatment of lipid disorder | |||
==== | :Triglyceride level should be less than 150 mg/dL (1.7 mmol/L) and favorable HDL levels is >40 mg/dL (1.0 mmol/L) for men and >50 mg/dL (1.3 mmol/L) for women. | ||
:Statin treatment for preventive measures should be considered for all diabetic patients older than 40 years. The following table summarizes the statin therapy strategies: | |||
*Blood pressure control | |||
:Blood pressure should be measured in every visits. Goal of blood pressure is less than 140/90 | |||
*Smoking cessation | |||
*Using Aspirin | |||
*Weight reduction | |||
*Vaccination including, annual influenza, pneumococcal vaccination and hepatitis B. | |||
*Regular dental care | |||
*Regular foot care | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Primary care]] | [[Category:Primary care]] | ||
Revision as of 18:16, 17 March 2017
|
Diabetes mellitus type 2 Microchapters |
|
Differentiating Diabetes Mellitus Type 2 from other Diseases |
|
Diagnosis |
|
Treatment |
|
Medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
Secondary Prevention
Secondary prevention is focused to decrease the macrovascular complications. Application of effective strategies can result in up to 50% risk reduction in macrovascular complications.[1] Effective measures in this case include:[2]
- Glycemic control
- Treatment of lipid disorder
- Triglyceride level should be less than 150 mg/dL (1.7 mmol/L) and favorable HDL levels is >40 mg/dL (1.0 mmol/L) for men and >50 mg/dL (1.3 mmol/L) for women.
- Statin treatment for preventive measures should be considered for all diabetic patients older than 40 years. The following table summarizes the statin therapy strategies:
- Blood pressure control
- Blood pressure should be measured in every visits. Goal of blood pressure is less than 140/90
- Smoking cessation
- Using Aspirin
- Weight reduction
- Vaccination including, annual influenza, pneumococcal vaccination and hepatitis B.
- Regular dental care
- Regular foot care
References
- ↑ Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O (2003). "Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes". N. Engl. J. Med. 348 (5): 383–93. doi:10.1056/NEJMoa021778. PMID 12556541.
- ↑ Saydah SH, Fradkin J, Cowie CC (2004). "Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes". JAMA. 291 (3): 335–42. doi:10.1001/jama.291.3.335. PMID 14734596.